Showing results (521-530 of 533) with videos related to
Sort By:
Pageof 54
Hepatology (Baltimore, Md.)|May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.Hepatology Communications|March 25, 2025
Moderate alcohol-associated hepatitis: A real-world multicenter studyFrancisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, et al.Journal of Hepatology|November 20, 2023
Global survey of stigma among physicians and patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A Alqahtani, Khalid Alswat, et al.JHEP Reports : Innovation in Hepatology|July 18, 2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A AlQahtani, Jesús Funuyet-Salas, et al.JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational StudyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.Hepatology (Baltimore, Md.)|October 16, 2025
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.Hepatology Communications|July 28, 2026
Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALDHyundam Gu, Luis Antonio Díaz, Natalia Baeza, et al.Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.Pageof 54